Abbott India (500488) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
6 Nov, 2025Executive summary
Unaudited financial results for the quarter and six months ended September 30, 2025, were approved by the Board and reviewed by statutory auditors without qualifications.
Financial highlights
Revenue from operations for Q2 FY26 was ₹1,757.15 crore, up from ₹1,632.67 crore in Q2 FY25.
Net profit for Q2 FY26 stood at ₹415.27 crore, compared to ₹365.86 crore in Q2 FY25.
Earnings per share for Q2 FY26 was ₹195.42, up from ₹168.76 in Q2 FY25.
Total comprehensive income for H1 FY26 was ₹781.20 crore, compared to ₹686.64 crore in H1 FY25.
Key financial ratios and metrics
Gross margin improved year-over-year, with total expenses for Q2 FY26 at ₹1,281.17 crore versus ₹1,213.72 crore in Q2 FY25.
Cash and cash equivalents as of September 30, 2025, were ₹591.10 crore, up from ₹560.59 crore as of March 31, 2025.
Net cash generated from operating activities for H1 FY26 was ₹521.94 crore, compared to ₹481.95 crore in H1 FY25.
Latest events from Abbott India
- Quarterly profit and revenue increased year-over-year, with new labour codes impacting costs.500488
Q3 25/2612 Feb 2026 - Q1 FY25 saw strong revenue and profit growth, with EPS up 13% year-over-year.500488
Q1 24/2520 Nov 2025 - Quarterly profit and revenue increased year-over-year, with strong cash and no audit concerns.500488
Q2 24/2520 Nov 2025 - Strong revenue and profit growth with robust margins and clean audit for the latest quarter.500488
Q3 24/2525 Aug 2025 - Net profit rose to ₹1,414.44 crore with a higher dividend and strong cash flow for FY25.500488
Q4 24/2525 Aug 2025 - Revenue and profit rose year-over-year, with strong EPS growth and clean auditor review.500488
Q1 25/2625 Aug 2025